|
2023-11-26 Government Corruption
|
|
Pfizer Failed To Disclose Risks Of Preterm Birth And Neonatal Death To Pregnant Women In RSV Vaccine Trial
|
 [ZERO] Even though Pfizer knew about the potential safety signal and was studying preterm births as an "adverse event of special interest," it continued to enroll women in its clinical trial and did not fully inform participants of the risks the vaccine may pose to their babies—and in some cases, provided misleading and contradictory statements, according to an investigation by The BMJ.
"The BMJ article demonstrates Pfizer’s continued disregard for the law and patient choice," attorney Thomas Renz told The Epoch Times in an email. "The entire point of informed consent is to ensure a patient can make a decision based on all available information. Rather than embracing the Nuremberg Code and American laws and regulations, Pfizer seems to view informed consent as a barrier to sales—something that causes vaccine hesitancy or drug hesitancy."
"There should have never been a clinical trial in pregnant women studying any injections aimed at RSV in pregnant women," Sasha Latypova told The Epoch Times in an email. "Pregnancy and potential to become pregnant is historically the most protected class of human subjects from clinical research because the risks and potential to cause inadvertent harm are too devastating to justify scientific interest in made-up subjects like RSV."
Ms. Latypova is a retired pharmaceutical industry executive with 25 years of experience in pharmaceutical research and development and co-founder of several organizations that work with pharmaceutical companies to design, execute, collect data, and submit clinical trial data to the U.S. Food and Drug Administration (FDA).
According to Ms. Latypova, what was once considered a harmless cold has since been rebranded as RSV.
"The vast majority of parents have not heard of RSV if they have not been exposed to CDC fear-mongering and renaming of otherwise harmless common colds. The incidence or prevalence of RSV is not known precisely because it poses no danger to anyone," Ms. Latypova said. "In the U.S., RSV is attributed as a cause of death to about 17 infants per year out of 4,000,000+ babies—based on a review of 12 years' worth of death certificates."
According to the Centers for Disease Control and Prevention (CDC), RSV is a common respiratory virus that usually causes mild, cold-like symptoms. Although most people recover in a week or two, it can be serious and is more commonly diagnosed in infants.
Both GSK and Pfizer were developing an RSV vaccine for pregnant women, but GSK halted its phase 3 vaccine trial in February 2022 over a possible increased risk of preterm births and neonatal deaths in vaccinated participants. 
|
Posted by Besoeker 2023-11-26 08:21||
||
Front Page|| [22 views ]
Top
|
|
Posted by Besoeker 2023-11-26 08:26||
2023-11-26 08:26||
Front Page
Top
|
|
Posted by Super Hose 2023-11-26 16:17||
2023-11-26 16:17||
Front Page
Top
|
|
16:03 alanc
15:43 Procopius2k
15:28 Abu Uluque
15:26 Abu Uluque
15:08 M. Murcek
15:06 Besoeker
14:59 ACA JOE
14:58 Grom the Reflective
14:55 swksvolFF
14:48 Besoeker
14:11 NoMoreBS
14:00 Procopius2k
13:58 Procopius2k
13:23 Crusader
13:19 Frank G
13:11 Frank G
13:11 SteveS
13:06 Skidmark
13:04 Rex Mundi
13:02 Skidmark
12:58 Rex Mundi
12:57 Rex Mundi
12:55 Rex Mundi
12:52 Skidmark
|
